BrightSpring Health Services Inc has a consensus price target of $18.81 based on the ratings of 14 analysts. The high is $27 issued by CJS Securities on December 12, 2024. The low is $11.5 issued by Deutsche Bank on February 20, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, CJS Securities, and B of A Securities on December 17, 2024, December 12, 2024, and December 11, 2024, respectively. With an average price target of $22.67 between Morgan Stanley, CJS Securities, and B of A Securities, there's an implied 31.25% upside for BrightSpring Health Services Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for BrightSpring Health (NASDAQ:BTSG) was reported by Morgan Stanley on December 17, 2024. The analyst firm set a price target for $20.00 expecting BTSG to rise to within 12 months (a possible 15.81% upside). 23 analyst firms have reported ratings in the last year.
The latest analyst rating for BrightSpring Health (NASDAQ:BTSG) was provided by Morgan Stanley, and BrightSpring Health maintained their overweight rating.
There is no last upgrade for BrightSpring Health
There is no last downgrade for BrightSpring Health.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on December 17, 2024 so you should expect the next rating to be made available sometime around December 17, 2025.
While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a maintained with a price target of $19.00 to $20.00. The current price BrightSpring Health (BTSG) is trading at is $17.27, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.